Go Back
This abstract was viewed 63 times

Dental Article


Unicystic Ameloblastoma Masquerading as Huge Periapical Lesion, both Clinically and Histopathologically: Two Case Reports with Review of Literature.

N V V SatyabhusanSamapika RoutrayLavanya BendiB Venkat SureshSumit MajumdarNeeta Mohanty
Departments of Oral and Maxillofacial Surgery, and Oral Pathology and Microbiology, Institute of Dental Sciences, Siksha O Anusandhan University, Bhubaneswar, Odisha, Oral Pathology and Microbiology, GITAM Dental College and Hospital, Gandhinagar Campus, Rushikonda, Vishakapatanam, Andhra Pradesh, India
Date of Submission: 05-Jul-2013, Date of Acceptance: 20-Aug-2013, Date of Web Publication: 30-Sep-2013.
Corresponding Author:

Samapika Routray

Department of Oral Pathology and Microbiology,Institute of Dental Sciences, Siksha O Anusandhan University, Bhubaneswar ‑ 751 003, Odisha, India.
E-mail: drroutray.samapika@gmail.com

Corresponding Author:

Samapika Routray

Department of Oral Pathology and Microbiology,Institute of Dental Sciences, Siksha O Anusandhan University, Bhubaneswar ‑ 751 003, Odisha, India.
E-mail: drroutray.samapika@gmail.com

DOI: 10.4103/2156-7514.119156 Facebook Twitter Google Linkedin

ABSTRACT


Unicystic ameloblastoma (UA) is one of the variants of ameloblastoma. It manifests as unilocular radiolucency in the mandible or maxilla on X-ray scans. In very rare cases, it can appear as a localized periradicular radiolucent area, imitating a periapical lesion. In this article, we present two cases of UA that were initially misdiagnosed as periapical lesions. Subsequently, surgical enucleation was performed and the diagnosis of UA was confirmed histopathologically.
Keywords: Ameloblastoma, Periapical Lesion, Unicystic Ameloblastoma, Unilocular Lesion

This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.